ALLEN YELVERTON: Open Payments
NPI 1710472790 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 24 payments from 14 companies in 2025. Trend: 2023 $211 · 2024 $630 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $73 |
| Exact Sciences Corporation | 3 | $52 |
| Novo Nordisk Inc | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Amgen Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Grifols USA, LLC | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
Products named: VRAYLAR, The Cologuard Plus Collection Kit, CAPLYTA, TRELEGY ELLIPTA, OTEZLA, Prolastin-C Liquid, Kerendia, MOUNJARO.
Industry payments across MS — which companies pay providers there.
